Showing results (51-60 of 145) with videos related to
Sort By:
Pageof 15
Natural Product Research|January 22, 2019
Variation in essential oil content and composition of Ridolfia segetum Moris based on 30-hour prolonged fractionated extraction procedureMijat Božović, Stefania Garzoli, Anna Baldisserotto, et al.Journal of Medicinal Chemistry|February 20, 2004
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activityAntonello Mai, Silvio Massa, Ilaria Cerbara, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|April 11, 2014
Effects of Mentha suaveolens Essential Oil Alone or in Combination with Other Drugs in Candida albicansAnnarita Stringaro, Elisabetta Vavala, Marisa Colone, et al.European Journal of Medicinal Chemistry|July 12, 2025
1,2,4-Oxadiazoles in medicinal chemistry: trends of the last yearsAnastasia Cherkasova, Roberta Astolfi, Maxim Nawrozkij, et al.Microorganisms|November 27, 2021
Anti-Virulence Properties of Coridothymus capitatus Essential Oil against Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis PatientsGianluca Vrenna, Marco Artini, Rino Ragno, et al.Natural Product Research|June 16, 2017
Essential oil extraction, chemical analysis and anti-Candida activity of Foeniculum vulgare Miller - new approachesStefania Garzoli, Mijat Božović, Anna Baldisserotto, et al.Journal of Medicinal Chemistry|March 7, 2025
An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase InhibitorsEmanuele Fabbrizi, Vladimir V Chernyshov, Francesco Fiorentino, et al.Journal of Chemical Information and Modeling|May 23, 2006
A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activityFabrizio Manetti, Cristina Tintori, Mercedes Armand-Ugón, et al.The Journal of Biological Chemistry|October 22, 2008
The tumor marker human placental protein 11 is an endoribonucleasePietro Laneve, Ubaldo Gioia, Rino Ragno, et al.Journal of Computer-Aided Molecular Design|January 17, 2018
Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approachesManuela Sabatino, Dante Rotili, Alexandros Patsilinakos, et al.Pageof 15